Canary Speech announces it has obtained HITRUST e1 Certification, reinforcing…
Read More »
Recursion Acquires Full Rights to REV102, a Potential First-in-Class Oral…
GE HealthCare’s Economic Impact Across Utah
RefloDx Wins Trans Atlantic Angel Grand Prize.
bioMérieux strengthens its next-generation sequencing capabilities with the acquisition of…
ALPHA-EMITTING RADIOISOTOPE EXPECTED TO PLAY AN ESSENTIAL ROLE IN NEXT-GENERATION…
Completion of SAD/MAD trial marks advancement toward further clinical development…
Strategic Expansion in Salt Lake City Headquarters Will Meet Stringent…
AGREEMENT PROVIDES RATIO ACCESS TO NUSANO-PRODUCED RADIOISOTOPES FOR ONCOLOGY DIAGNOSTICS…
Microvascular Therapeutics announces Founder and CEO Dr. Evan Unger as…
Groundbreaking Preclinical Data Propel Clinical Milestone
Rebel Medicine Announces Series A Financing and Investigational New Drug…
DOMESTIC STABLE ISOTOPE PROGRAM KEY TO STABILIZING SUPPLY CHAINS, ENABLING…
Using AI machine learning, the Company discovers distinct biomarkers for…
Bioseeker™ is the AI Discovery Engine Powering Seek Labs’ Mission…
Halia Therapeutics Completes Enrollment in Phase 2a Clinical Trial of…
Screening test provides prenatal risk assessment for common genetic conditions…
Renalytix collaborates with NYKHM to bring kidneyintelX.dkd testing to underserved…
Dr. George Katibah and Dr. Adam Grant describe the features…
Two Molecular Residual Disease (MRD) studies highlighting clinical data among…
Notifications
